APA (7th ed.) Citation

Nicot, C. (2025). CircRNA aptamer targets IGF2BP2 to overcome acquired BETi resistance. Molecular Cancer, 24(1), 1. https://doi.org/10.1186/s12943-025-02423-6

Chicago Style (17th ed.) Citation

Nicot, Christophe. "CircRNA Aptamer Targets IGF2BP2 to Overcome Acquired BETi Resistance." Molecular Cancer 24, no. 1 (2025): 1. https://doi.org/10.1186/s12943-025-02423-6.

MLA (9th ed.) Citation

Nicot, Christophe. "CircRNA Aptamer Targets IGF2BP2 to Overcome Acquired BETi Resistance." Molecular Cancer, vol. 24, no. 1, 2025, p. 1, https://doi.org/10.1186/s12943-025-02423-6.

Warning: These citations may not always be 100% accurate.